lysophosphatidic acid has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, M; Dong, Y; Fukushima, N; Hirane, M; Honoki, K; Tsujiuchi, T | 1 |
| Araki, M; Dong, Y; Fukushima, N; Hirane, M; Honoki, K; Kitayoshi, M; Mori, S; Ozaki, S; Tsujiuchi, T | 1 |
| Fukushima, N; Honoki, K; Kitayoshi, M; Shibata, A; Tanabe, E; Tsujiuchi, T; Yoshikawa, K | 1 |
3 other study(ies) available for lysophosphatidic acid and Sarcoma
| Article | Year |
|---|---|
Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.
Topics: Cell Line, Tumor; Cell Movement; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid; Sarcoma; Signal Transduction | 2014 |
Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chlorocebus aethiops; COS Cells; Endothelial Cells; Lysophospholipids; Matrix Metalloproteinase 2; Rats; Receptors, Lysophosphatidic Acid; Sarcoma; Vascular Endothelial Growth Factor A | 2014 |
Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells.
Topics: Cell Line, Tumor; Cell Movement; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasms; Receptors, Lysophosphatidic Acid; Sarcoma; Signal Transduction | 2012 |